- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04670848
Contactless Detection of Sleep Apnea
January 24, 2022 updated by: Sleepiz AG
Validation of a Contactless Sensor for Sleep Apnea Diagnosis Against Polysomnography
In this study the inestigators aim to validate the performance of Sleepiz One+ for sleep apnea detection during routine diagnostic sleep studies.
Patients who are prescribed polysomnography study will be asked to participate and undergo a simultaneous sleep recording with radar sensor-based device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
116
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Rhine-Westphalia
-
Essen, North Rhine-Westphalia, Germany, 45239
- Universitätsmedizin Essen Ruhrlandklinik
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age >18years
- Ability and consent to undergo electrophysiological routine assessment
- Patients suspected to suffer from sleep apnea or any other sleep related disorder
Exclusion Criteria:
- Previous enrollment into the current study,
- Enrollment of the investigator, his/her family members and other dependent persons
- Cardiac pacemaker or another implanted electrical device
- Women who are pregnant or breastfeeding
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Patients suspected of suffering from sleep apnea
|
Simultaneous sleep recording with polysomnography and Sleepiz One+ device
|
|
EXPERIMENTAL: Healthy volunteers
|
Simultaneous sleep recording with polysomnography and Sleepiz One+ device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Binary classification of subjects based on their sleep apnea severity (AHI ≥= 15) made by Sleepiz One+, compared to PSG data manually scored by sleep technicians
Time Frame: 1 Night
|
1 Night
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christoph Schöbel, Prof. Dr. med., Universitätsmedizin Essen Ruhrlandklinik
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 7, 2020
Primary Completion (ACTUAL)
December 21, 2021
Study Completion (ACTUAL)
December 21, 2021
Study Registration Dates
First Submitted
December 9, 2020
First Submitted That Met QC Criteria
December 15, 2020
First Posted (ACTUAL)
December 17, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 25, 2022
Last Update Submitted That Met QC Criteria
January 24, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSG-Apnea-Essen
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Apnea
-
Hospital Felicio RochoNot yet recruitingSleep Apnea/Hypopnea Syndrome | Sleep Apnea Syndrome, Obstructive | Sleep Apnea Syndrome (OSAS) | Sleep Apnea - Obstructive
-
Mardin Artuklu UniversityNot yet recruitingObstructive Sleep Apnea | Sleep ApneaTurkey (Türkiye)
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); ResMed FoundationRecruitingObstructive Sleep Apnea | Sleep ApneaUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Not yet recruitingCentral Sleep Apnea | Maxillomandibular Advancement Surgery | Sleep Apnea Syndrome (OSAS) | Orthognathic Surgical ProceduresNetherlands
-
ResMedCRI-The Clinical Research Institute GmbH; University Hospital RegensburgCompletedObstructive Sleep Apnea | Central Sleep Apnea | Mixed Sleep Apnea | Complex Sleep ApneaSwitzerland, Spain, Denmark, Portugal, France, Germany
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Hospices Civils de LyonNot yet recruitingObstructive Sleep ApneaFrance
-
University Hospital, AntwerpNot yet recruiting
-
Nyxoah Inc.Not yet recruitingObstructive Sleep ApneaUnited States
Clinical Trials on Sleepiz One+ vs. polysomnography
-
Sleepiz AGCompleted
-
Sleepiz AGRecruitingCardiovascular Diseases | Hypertension | Diabetes | Asthma | Sleep Apnea | COPD | Respiratory DiseaseSwitzerland
-
Sleepiz AGCompletedHeart Diseases | Hypertension | Asthma | Sleep Apnea | COPD | Respiratory DiseaseSwitzerland
-
Samuel TschoppSleepiz AG, Hornbachstrasse 23, 8008 Zurich, info@sleepiz.com, 004122 575...CompletedObstructive Sleep Apnea | Sleep Apnea | Respiratory Tract Disease | Respiration DisorderSwitzerland
-
Sleepiz AGRecruitingStroke | Sleep ApneaSwitzerland
-
DreemCompletedSleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Insomnia, SecondaryUnited States
-
University of British ColumbiaCompletedObstructive Sleep ApneaCanada
-
Al-Azhar University - GazaNot yet recruitingNeck of Femur Fracture | Orthopaedic Disorders
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam